Skip to main content
Opthea Ltd logo

Opthea Ltd — Investor Relations & Filings

Ticker · OPT ISIN · US68386J2087 LEI · 549300Q5FMFDLP46SF83 ASX Manufacturing
Open in API
Filings indexed 1,390 across all filing types
Latest filing 2017-04-26 Director's Dealing
Country AU Australia
Listing ASX OPT

About Opthea Ltd

https://opthea.com/

Opthea is a clinical-stage biopharmaceutical company focused on developing novel therapies for vision-threatening retinal diseases, particularly wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company's lead product candidate, sozinibercept, is a first-in-class biologic 'trap' inhibitor targeting Vascular Endothelial Growth Factors C and D (VEGF-C and VEGF-D). Sozinibercept is being developed for administration in combination with standard-of-care anti-VEGF-A therapies. This dual-pathway inhibition aims to deliver superior visual outcomes by more comprehensively blocking the mechanisms that contribute to disease progression, addressing the limitations of current treatments that only target VEGF-A. The therapy is being evaluated in late-stage pivotal clinical trials for wet AMD.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - MS 2 pages 86.4KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including the number of shares held before and after the change, the nature of the interest, and the transaction type (on-market trade). This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document length is 3890 characters, which is typical for such notices. There is no indication that this is a full financial report or other filing type. Therefore, the correct classification is Director's Dealing (DIRS).
2017-04-26 English
Ceasing to be a substantial holder 3 pages 136.0KB
Regulatory Filings Classification · 90% confidence The document text is extremely short (595 characters) and contains mostly placeholders for omitted pictures and tables with no substantive financial data or narrative content. There is no indication of detailed financial statements, management discussion, or regulatory certifications. The content does not resemble a full report but rather appears to be a fragment or a placeholder document. Given the brevity and lack of report content, this is likely a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other specific categories.
2017-04-20 English
Change in substantial holding 17 pages 6.7MB
Regulatory Filings
2017-04-17 English
Appendix 3B 16 pages 228.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement from Opthea Limited regarding the issuance of new shares through a placement and an institutional entitlement offer. It includes detailed information about the number of shares issued, the issue price, dilution effects, compliance with ASX Listing Rules, and an Appendix 3B form which is a standard Australian Securities Exchange (ASX) form for new issue announcements and applications for quotation of additional securities. The content focuses on capital raising activities and share issuance rather than financial results, management changes, or other report types. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback, but a substantive update on capital raising.
2017-04-11 English
Placement Cleansing Statement 1 page 58.2KB
Capital/Financing Update Classification · 95% confidence The document is a notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) regarding the issuance of fully paid ordinary shares by Opthea Limited. It references compliance with disclosure requirements and the issuance of shares to professional and sophisticated investors. The content focuses on a capital raising event and legal compliance related to share issuance, not a full financial report or earnings release. The document length is short (1640 characters) and it is a formal announcement of a capital transaction. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2017-04-11 English
Opthea Retail Entitlement Offer Booklet 69 pages 15.5MB
Capital/Financing Update Classification · 100% confidence The document is titled 'Retail Entitlement Offer Booklet' and details a 1 for 14 accelerated non-renounceable entitlement offer of shares by Opthea Limited. It includes information about the offer price, key dates, instructions on how to apply, and the purpose of the capital raising. The document is a detailed booklet intended for shareholders to participate in a capital raising event. It is not a financial report, earnings release, or management discussion. It is clearly related to a capital raising activity, specifically an entitlement offer, which is a form of financing. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is the offer booklet itself, not just an announcement of the offer. Hence, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2017-04-09 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.